Alkem Laboratories Limited - stock earnings
ALKEM.BO Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| May 16, 2024 BeforeMarket | - / - | - | - / 18.4 billion | - |
ALKEM.BO Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | 5.9 billion INR | 33.2 billion INR |
| 2023Q3 | 6.2 billion INR | 34.4 billion INR |
| 2023Q2 | 2.9 billion INR | 29.7 billion INR |
| 2023Q1 | 709.8 million INR | 29.0 billion INR |
| 2022Q4 | 4.5 billion INR | 30.4 billion INR |
| 2022Q3 | 3.3 billion INR | 30.8 billion INR |
| 2022Q2 | 1.3 billion INR | 25.8 billion INR |
| 2022Q1 | 1.1 billion INR | 23.6 billion INR |
| 2021Q4 | 5.3 billion INR | 26.2 billion INR |
| 2021Q3 | 5.4 billion INR | 28.0 billion INR |
| 2021Q2 | 4.7 billion INR | 27.3 billion INR |
| 2021Q1 | 2.4 billion INR | 20.6 billion INR |
| 2020Q4 | 4.5 billion INR | 23.2 billion INR |
| 2020Q3 | 4.7 billion INR | 23.6 billion INR |
| 2020Q2 | 4.2 billion INR | 20.0 billion INR |
| 2020Q1 | 1.9 billion INR | 19.0 billion INR |
| 2019Q4 | 3.8 billion INR | 21.8 billion INR |
| 2019Q3 | 3.7 billion INR | 22.6 billion INR |
| 2019Q2 | 1.9 billion INR | 18.5 billion INR |
| 2019Q1 | 1.7 billion INR | 17.6 billion INR |
| 2018Q4 | 2.0 billion INR | 19.3 billion INR |
| 2018Q3 | 2.5 billion INR | 19.2 billion INR |
| 2018Q2 | 1.4 billion INR | 16.7 billion INR |
| 2018Q1 | 670.8 million INR | 15.1 billion INR |
| 2017Q4 | 1.7 billion INR | 17.4 billion INR |
| 2017Q3 | 3.2 billion INR | 18.6 billion INR |
| 2017Q2 | 715.6 million INR | 13.0 billion INR |
| 2017Q1 | 1.4 billion INR | 12.5 billion INR |
| 2016Q4 | 2.3 billion INR | 14.6 billion INR |
| 2016Q3 | 2.8 billion INR | 16.2 billion INR |
| 2016Q2 | 2.4 billion INR | 14.4 billion INR |
| 2016Q1 | 866.8 million INR | 11.5 billion INR |
| 2015Q4 | 1.9 billion INR | 12.5 billion INR |
| 2015Q3 | 2.7 billion INR | 13.6 billion INR |
| 2015Q2 | 2.0 billion INR | 12.0 billion INR |
| 2015Q1 | 1.3 billion INR | 9.6 billion INR |
| 2014Q4 | 1.6 billion INR | 9.7 billion INR |
| 2014Q3 | 855.9 million INR | 9.4 billion INR |
| 2014Q2 | 855.9 million INR | 9.4 billion INR |
ALKEM.BO Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 9.8 billion INR | 116.0 billion INR |
| 2022 | 16.5 billion INR | 105.1 billion INR |
| 2021 | 15.9 billion INR | 87.3 billion INR |
| 2020 | 11.3 billion INR | 81.9 billion INR |
| 2019 | 7.6 billion INR | 72.7 billion INR |
| 2018 | 6.3 billion INR | 63.1 billion INR |
| 2017 | 8.9 billion INR | 56.2 billion INR |
| 2016 | 6.7 billion INR | 49.6 billion INR |
| 2015 | 3.9 billion INR | 37.2 billion INR |
| 2014 | 4.4 billion INR | 27.0 billion INR |
| 2013 | 5.0 billion INR | 23.2 billion INR |
| 2012 | 4.3 billion INR | 19.5 billion INR |
| 2011 | 3.3 billion INR | 16.3 billion INR |
| 2010 | 2.4 billion INR | 13.4 billion INR |
ALKEM.BO
Price: ₹5,438.80
Dividend Yield: 0.83%
Forward Dividend Yield: 1.29%
Payout Ratio: 53.24%
Dividend Per Share: 70.00 INR
Earnings Per Share: 131.80 INR
P/E Ratio: 39.14
Exchange: BSE
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 650.2 billion
Average Dividend Frequency: 2
Years Paying Dividends: 9
DGR3: 0.40%
DGR5: 20.24%